Inovio Execs Hit With Suit On Heels Of COVID-19 Class Action
An investor hit Inovio Pharmaceuticals Inc. executives with a derivative action on behalf of the company in Pennsylvania federal court Monday, accusing the board of directors of lying about the successful...To view the full article, register now.
Already a subscriber? Click here to view full article